Linked Life Data

12680474

Source:http://linkedlifedata.com/resource/pubmed/id/12680474

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2003-4-8
pubmed:abstractText
To assess the effect of basiliximab (BAS) induction therapy on acute rejection rates and overall costs in adult living related donor (LRD) renal transplant recipients. Design. Retrospective chart review and cost-effectiveness analysis of the first 12 months after transplantation.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0277-0008
pubmed:author
pubmed:issnType
Print
pubmed:volume
23
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
443-50
pubmed:dateRevised
2005-11-17
pubmed:meshHeading
pubmed:year
2003
pubmed:articleTitle
Lack of economic benefit with basiliximab induction in living related donor adult renal transplant recipients.
pubmed:affiliation
Solid Organ Transplant Program, College of Pharmacy , University of Utah, Salt Lake City, Utah 84132-2330, USA.
pubmed:publicationType
Journal Article